Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. Scores detected baseline and differences between carriers and noncarriers https://t.c…
RT @UCSFmac: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMI…
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint. Longitudinal changes can be detected in presymptomatic and mildly symptomatic stages.…
Assessment of executive function declines in presymptomatic and mildly symptomatic familial FTD: NIH‐EXAMINER as a potential clinical trial endpoint. NIH-EXAMINER declines were associated with worsening clinical symptoms and brain volume loss. https://t.c…